Nalbuphine

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Trevi Therapeutics
Trevi TherapeuticsNEW HAVEN, CT
2 programs
2
Nalbuphine ERPhase 11 trial
Nalbuphine HCl solutionPhase 11 trial
Active Trials
NCT04020016UnknownEst. Dec 2020
NCT04018664CompletedEst. Jun 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Trevi TherapeuticsNalbuphine ER
Trevi TherapeuticsNalbuphine HCl solution

Clinical Trials (2)

NCT04020016Trevi TherapeuticsNalbuphine ER

Nalbuphine ER Effects of Liver Disease on Pharmacokinetics and Itch

Start: Oct 2018Est. completion: Dec 2020
Phase 1Unknown
NCT04018664Trevi TherapeuticsNalbuphine HCl solution

Oral Abuse Potential Study of Nalbuphine

Start: May 2018Est. completion: Jun 2020
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space